Bone Loss in the Elderly
Overview
Orthopedics
Affiliations
A large number of cross-sectional studies suggest that rates of bone loss decrease in the elderly, particularly at the spine and radius. For this reason it has been argued that bone mass measurements are unhelpful in assessing fracture risk in the elderly and that drugs affecting bone metabolism are less likely to be of benefit in reducing this risk. This paper reviews the assumptions on which these conclusions are based and argues that in many instances they are flawed. Indeed, studies examining rates of bone loss in the elderly either directly or by biochemical indices of bone turnover suggest that bone loss continues throughout life and may even accelerate after the age of 70 years. This conclusion supports the view that identification of patients at risk and subsequent treatment is of value in all age groups.
Osteoporosis and fracture risk are multifactorial in patients with inflammatory rheumatic diseases.
Buttgereit F, Palmowski A, Bond M, Adami G, Dejaco C Nat Rev Rheumatol. 2024; 20(7):417-431.
PMID: 38831028 DOI: 10.1038/s41584-024-01120-w.
Cheung W, Hung V, Cheuk K, Chau W, Tsoi K, Wong R J Bone Miner Res. 2021; 36(12):2381-2398.
PMID: 34585784 PMC: 9298023. DOI: 10.1002/jbmr.4449.
Sorensen V, Wojtek P, Pedersen D, Andersen S J Endocrinol Invest. 2015; 38(8):841-7.
PMID: 26122488 DOI: 10.1007/s40618-015-0343-2.
Bone morphology in 46 BXD recombinant inbred strains and femur-tibia correlation.
Zhang Y, Huang J, Jiao Y, David V, Kocak M, Roan E ScientificWorldJournal. 2015; 2015:728278.
PMID: 25811045 PMC: 4355808. DOI: 10.1155/2015/728278.
Addressing the age-related needs of osteoporotic patients with strontium ranelate.
Boonen S Osteoporos Int. 2010; 21 Suppl 2:S415-23.
PMID: 20464375 DOI: 10.1007/s00198-010-1231-4.